The worldwide seasonal affective disorder market was valued at USD 550 million in 2021 and is expected to reach over USD 950 million in 2030, with a CAGR of 5.5% during the forecast period.
The rising demand for Seasonal Affective Disorder in hospitals, clinics, households, and other applications throughout the world is driving market expansion. The research discusses the profitable potential in the Seasonal Affective Disorder Market at the country level. The research also contains a detailed cost, segmentation, trends, region, and commercial development of the world’s leading important players for the projected time.
The report considers a variety of factors, including product pricing, product or service penetration at both the national and regional levels, country GDP, market dynamics of the parent and child markets, end application industries, major players, consumer purchasing behavior, economic, political, and social scenarios of countries, and many others. The study is broken into parts to provide a comprehensive overview of the industry from all angles.
Get a Sample Copy of the Report – https://wemarketresearch.com/sample-request/seasonal-affective-disorder-market/941
Seasonal Affective Disorder Market Segmentation
By Treatment
- Self-Care
- Psychotherapy
- Phototherapy
- Medications
- Mind-Body Techniques and Others
Key Company
Henry Schein Inc., Bristol-Myers Squibb, Allergan, Bayer AG, Koninklijke Philips N.V., Bausch Health, Mylan, Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Eli Lily and Company, Sanofi, Novartis AG, GlaxoSmithKline, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services Inc., and Other Players
Regional Insights
North America is predicted to lead the worldwide market in terms of market share during the estimated period due to a rise in the incidence of seasonal depressions. About 5% of the US population suffers from seasonal affective disorder. This is attributed to changing lifestyles and an increase in knowledge of seasonal depression and its treatment.
Seasonal affective disorder is less common in Asia and the Pacific, though. Increased awareness, a growing senior population, and an increase in medical tourism in emerging economies like China and India are all expected to drive market expansion in the area.
Market Trend
The growing prevalence of seasonal affective disorder and depression, as well as enhanced R&D efforts, are propelling market growth. For example, according to American Psychiatric Association data updated in October 2020, 5% of individuals in the United States suffer from seasonal affective Disorder (SAD), a kind of depression that peaks in the winter.
Furthermore, according to a September 2021 report from the National Health Service in the United Kingdom, more than one-third of 16-year-olds have SAD, fear they have SAD or experience low moods throughout the autumn and winter. Seasonal Affective Disorder affects one out of every twenty persons in the United Kingdom. According to the study, women are more likely than men to report having a negative mood throughout the fall and winter (18.28 percent vs. 12.87 percent). Such factors have increased the global Seasonal Affective Disorder market CAGR in recent years.
Furthermore, according to the Anxiety and Depression Foundation statistics and figures, which were updated in June 2022, generalized anxiety disorder affects 6.8 million individuals, or 3.1% of the US population each year. As a result, rising rates of depression and SADs throughout the world are expected to enhance global Seasonal Affective Disorder market revenue over the forecast period.
Scope of the Report
This study provides history, present, and future information and estimates for the Seasonal Affective Disorder Market. The report’s market estimations are based on a comprehensive research approach. The research process used includes many channels of research, such as primary research, secondary research, and subject-related expert opinion. The market estimations are produced using the current market dynamics as well as many economic, social, and political aspects affecting the Seasonal Affective Disorder Market. The market data is also defined by numerous legislation, government investments, and increased R&D. The market projections take into account both positive and negative developments in the market.
Purchase this Report – https://wemarketresearch.com/purchase/seasonal-affective-disorder-market/941?license=single
About We Market Research
We Market Research is a well-established market analytics and research organization with a diverse range of industry experience. We have been working on multi-county market research since our start. Throughout our history, we have earned accolades for our thorough market research and analytical analysis of many industry segments.
Our strategic market analysis and ability to appreciate the profound cultural, philosophical, and sociological components of many complex markets have helped us establish a name for ourselves in the business. WE MARKET RESEARCH is a market leader in assisting several regional and worldwide firms in effectively achieving their business objectives via our in-depth market analysis. Furthermore, we may develop market strategies that ensure our clients have a consistent consumer base.
Contact Us
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: [email protected]
